Abstract
The complex pathophysiology of adult respiratory distress syndrome (ARDS) makes preventive and therapeutic concepts difficult. Ample experimental evidence indicates that ARDS can be prevented by blocking systemic inflammatory agents. Clinically, only heparin, for inhibition of coagulation phenomena, is presently used among this array of approaches. Corticosteroids have not proven to be beneficial in ARDS. Alternative antiinflammatory agents are being proposed and are under current clinical investigation (e.g. indomethacin, acetylcysteine, αl-proteinase inhibitor, antitumor necrosis factor, interleukin 1 receptor antagonist, platelet-activating factor antagonists). Symptomatic therapeutic strategies in early ARDS include selective pulmonary vasodilation (preferably by inhaled vasorelaxant agents) and optimal fluid balance. Transbronchial surfactant application, presently tested in pilot studies, may be available for ARDS patients in the near future and may have acute beneficial effects on gas exchange, pulmonary mechanics, and lung hemodynamics; its impact on survival cannot be predicted at the present time. Strong efforts should be taken to reduce secondary nosocomial pneumonia in ARDS patients and thus avoid the vicious circle of pneumonia, sepsis from lung infection, and perpetuation of multiple organ dysfunction syndrome. Optimal respirator therapy should be directed to ameliorate gas-exchange conditions acutely but at the same time should aim at minimizing potentially aggravating side effects of artificial ventilation (barotrauma, O2 toxicity). Several new techniques of mechanical ventilation and the concept of permissive hypercapnia address these aspects. Approaches with extracorporeal CO2 removal and oxygenation are being used in specialized centers.
Article PDF
Similar content being viewed by others
References
Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2: 319–323
Avery ME, Merritt TA (1991) Surfactant-replacement therapy. N Engl J Med 324: 910–911
Bell RC, Coalson JJ, Smith JD, Johanson WG Jr (1983) Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 9: 293–298
Benzer H (1991) Therapie der akuten respiratorischen Insuffizienz. In: Kilian J, Benzer H, Ahnefeld FW (eds) Grundzüge der Beatmung, vol. 39. Springer-Verlag, Berlin, chapter 5
Berg JT, Allison RC, Ravi Prasad V, Taylor A (1990) Endotoxin protection of rats from pulmonary oxygen toxicity: possible cytokine involvement. J Appl Physiol 68: 549–553
Bernard GR, Luce JM, Sprung LC, Rinaldo JE, Tate RM, Sibbald WJ, Kariman Khalil, Higgins St, Bradley R, Metz CA, Harris TR, Brigham KL (1987) High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 317: 1565–1570
Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, Chapman HA (1990) Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 322: 890–897
Bihari D, Smithies M, Gimson A, Tinker J (1987) The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med 317: 397–403
Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317: 653–658
Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA (1987) Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 92: 1032–1036
Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1989) Sepsis syndrome: a valid clinical entity. Crit Care Med 17: 389–393
Bone RC, Slotman G, Maunder R, Silvermann H, Ursprung JJ (1989) Randomized doubleblind, multicenter study of prostaglandin E, in patients with the adult respiratory distress syndrome. Chest 96: 114–119
Border JR, Hassett J, LaDuca J, Seibel R, Steinberg S, Mills B, Losi P, Border D (1987) The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU. Ann Surg 206: 427–448
Brichant JF, Rouby JJ, Viars P (1986) Intermittent positive pressure ventilation with either positive end-expiratory pressure or high frequency jet ventilation (HFJV), or HFJV alone in human acute respiratory failure. Anesth Analg 65: 1135–1142
Brigham KL, Meyrick B (1986) Endotoxin and lung injury. Am Rev Respir Dis 133: 913–927
Burchardi H (1986) Beatmungstechniken zur Optimierung der funktionellen Residualkkapazität. Intensivmed 23: 433–439
Carroll GC, Tuman KJ, Bravermann B, Logas WG, Wool N, Ivankovich AD (1988) Minimal positive end-expiratory pressure (PEEP) may be “best PEEP.” Chest 93: 1020–1025
Clarke C, Edwards JD, Nightingale P, Mortimer AJ, Morris J (1991) Persistence of supply dependency of oxygen uptake at high levels of delivery in adult respiratory distress syndrome. Crit Care Med 19: 497–502
Corbridge TC, Wood LDH, Crawford GP, Chudoba MJ, Yanos J, Sznajder JI (1990) Adverse effects of large tidal volume and low PEEP in canine acid aspiration. Am Rev Respir Dis 142: 311–315
Cox SC, Norwood SH, Duncan CA (1985) Acute respiratory failure: mortality associated with underlying disease. Crit Care Med 13: 1005–1008
Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR (1986) Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 133: 792–796
Cryer HG, Richardson JD, Longmire-Cook S, Brown CM (1989) Oxygen delivery in patients with adult respiratory distress syndrome who undergo surgery: correlation with multiplesystem organ failure. Arch Surg 124: 1378–1384
Demertzis S, Haverich A, Ziemer G, Nerlich M, Muller KM, Wagner TO, Borst HG (1992) Successful lung transplantation for posttraumatic adult respiratory distress syndrome after extracorporeal membrane oxygenation. J Heart Lung Transplant 11: 1005–1007
Dreyfuss D, Saumon G (1992) Barotrauma is volutrauma, but which volume is the one responsible? Intensive Care Med 18: 139–141
Driks MR, Craven CE, Cell BR, Manning M, Burke RA, Garvin GM, Kunchas LM, Farber HW, Wedel SA, McCabe WR (1987) Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N Engl J Med 317: 1376–1382
Egan TM, Duffin J, Glynn MFX, Todd TRJ, DeMajo W, Murphy E, Fox L, Cooper DJ (1988) Ten-year experience with extracorporeal membrane oxygenation for severe respiratory failure. Chest 94: 681–687
Egan TM (1992) When is lung transplantation appropriate? J Heart Lung Transplant 11: 1008
Eisenberg PR, Hansbrough JR, Anderson D, Schuster DP (1987) A prospective study of lung water measurements during patient management in an intensive care unit. Am Rev Respir Dis 136: 662–668
Farmer JC, Burkey TH, Kew RR, Webster RO (1991) Concentration-dependent regulatory effects of prostaglandin E1 on human neutrophil function in vitro. Am Rev Respir Dis 144: 593–599
First European Consensus Conference (1992) Selective digestive decontamination in intensive care unit patients. Intensive Care Med 18: 182–188
Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038–2047
Füssle R, Biscoping J, Michaelis G, Zeiler G, Sziegoleit A (1991) Intensive care patients: a high risk population for candida infections. Clin Intensive Care 2: 75–80
Gattioni L, Pelosi P, Vitale G, Pesenti A, D'Andrea L, Mascheroni D (1991) Body positive changes redistribute lung computed-tomography density in patients with acute respiratory failure. Anesthesiology 74: 15–23
Gilbert EM, Haupt MT, Mandanas RY, Huaringa AJ, Carlson RW (1986) The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am Rev Respir Dis 134: 873–878
Glauser FL, Polatty RC, Sessler CN (1988) Worsening oxygenation in the mechanically ventilated patient: causes, mechanisms, and early detection. Am Rev Respir Dis 138: 458–465
Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA, Hudson LD, Maunder RJ, Crim C, Hyers TM (1991) Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88: 1976–1981
Grimminger F, Seeger W (1990) Regulation inflammatorischer Abldufe: Angriffspunkte und Grenzen steroidaler Antiphlogistika. Med Welt 41: 951–964
Hack CE, Voerman HJ, Eisele B, Keinecke HO, Nuijens JH, Ehrenberg AM, Ogilvie A, Strack van Schijndel RJ, Delvos U, Thijs LG (1992) C1-esterase inhibitor substitution in sepsis. Lancet 339: 378
Haider M, Schad H (1989) Kontinuierliche Hämofiltration zur Therapie der akuten respiratorischen Insuffizienz. Intensivmed 26: 43–54
Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L (1982) Evidence of lung surfactant abnormalities in respiratory failure: study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 70: 673–683
Hardaway RM, Williams CH, Marvasti M, Farias M, Tseng A, Pinon I, Yanez D, Martinez M, Navar J (1990) Prevention of adult respiratory distress syndrome with plasminogen activator in pigs. Crit Care Med 18: 1413–1418
Hazinski TA, Kennedy KA, France ML, Hansen TN (1988) Pulmonary O2 toxicity in lambs: physiological and biochemical effects of endotoxin infusion. J Appl Physiol 65: 1579–1585
Hazinski TA, Kennedy KA, France ML (1988) Effect of endotoxin pretreatment on the pulmonary vascular response to hypoxia in O2-exposed lambs. J Appl Physiol 65: 1586–1588
Hennes HM, Lee MB, Rimm AA, Shapiro DL (1991) Surfactant replacement therapy in respiratory distress syndrome. Am J Dis Child 145: 102–104
Hickling KG (1990) Ventilatory management of ARDS: can it affect the outcome? Intensive Care Med 16: 219–226
Hickling KG, Henderson SJ, Jackson R (1990) Low mortality associated with low volume pressure limited ventilation with permissive hypercapnia in severe adult respiratory distress syndrome. Intensive Care Med 16: 372–377
High KM, Snider MT, Richard R, Russell GB, Stene JK, Campbell DB, Aufiero TX, Thieme GA (1992) Clinical trials of an intravenous oxygenator in patients with adult respiratory distress syndrome. Anesthesiology 77: 856–863
Hinson JR (1992) Principles of mechanical ventilator use in respiratory failure. Annu Rev Med 43: 341–361
Holcroft JW, Vassar MJ, Weber CJ (1986) Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. Ann Surg 203: 371–378
Holzapfel L, Robert D, Perrin F, Gaussorgues P, Guidicelli DP (1987) Comparison of high-frequency jet ventilation to conventional ventilation in adults with respiratory distress syndrome. Intensive Care Med 13: 100–105
Horstmann E, Pothoff G, Könn B, Daweke H (1989) Efolgreiche Behandlung eines Atemnotsyndroms (ARDS) bei der Legionärskrankheit durch Hämofiltration. Intensivmed 26: 206–209
Humphrey H, Hall J, Sznajder I, Silverstein M, Wood L (1990) Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 97: 1176–1180
Humphreys H, Winter R, Pick A (1992) The effect of selective decontamination of the digestive tract on gastrointestinal enterococcal colonization in ITU patients. Intensive Care Med 18: 459–463
Hurst JM, Branson RD, Davis K Jr, Barrette RR, Adams KS (1990) Comparison of conventional mechanical ventilation with high-frequency ventilation: a prospective, randomized trial in patients with respiratory failure. Ann Surg 211: 486–491
Idell S, Jammes KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, Martin TR, McLarty J, Fair DS (1989) Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 84: 695–705
Inglis TJJ, Sherratt MJ, Sproat LJ, Gibson JS, Hawkey PM (1993) Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung. Lancet 341: 911–913
Inthorn D, Mühlbayer D, Jochum M (1991) AT-111 Substitution in der postoperativen Sepsis. Ergebnisse einer prospektiven randomisierten Studie. Wien 1. and 2. März 1991: Wiener Intensivmedizinische Tage
Jamieson D (1989) Oxygen toxicity and reactive oxygen metabolites in mammals. Free Radical Biol & Med 7: 87–108
Jenkinson SG, Long RL, Lawrence RA (1984) Endotoxin protects selenium-deficient rats from hyperoxia. J Lab Clin Med 103: 143–152
Jenkinson SG (1989) Prostaglandin E1: not the magic bullet in ARDS. Chest 96: 1–2
Jobe AH (1993) Pulmonary surfactant therapy. N Engl J Med 328: 861–868
Joka T, Obertacke U (1989) Neue medikamentöse Behandlung im ARDS: Effekt einer intrabronchialen xenogenen Surfactantapplikation. Z Herz-, Thorax-, Gefäßschir 3: 21–24
Kallis P, Al-Saady NM, Bennett D, Treasure T (1991) Clinical use of intravascular oxygenation (letter). Lancet 337: 549
Kappstein I, Friedrich T, Hellinger P, Benzing A, Geiger K, Schulgen G, Daschner FD (1991) Incidence of pneumonia in mechanically ventilated patients treated with sucralfate or cimetidine as prophylaxis for stress bleeding: bacterial colonization of the stomach. Am J Med 1: 125S–132S
Kendig JW, Notter RH, Cox C, Reubens LJ, Davis JM, Maniscalco WM, Sinkin RA, Bartoletti A, Dweck HS, Horgan MJ (1991) A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks gestation. N Engl J Med 324: 865–871
Koizumi M, Frank L, Massaro D (1985) Oxygen toxicity in rats: varied effect of dexamethasone treatment depending on duration of hyperoxia. Am Rev Respir Dis 131: 907–911
Kunkel SL, Standiford T, Kasahara K, Strieter RM (1991) Interleucin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 17: 17–23
Lachmann B (1987) Is there a future for surfactant replacement therapy in the adult respiratory distress syndrome? Intensive Care 2: 1–6
Lachmann B (1987) The role of pulmonary surfactant in the pathogenesis and therapy of ARDS. In: Vincent JL (ed) Update in Intensive Care and Emergency Medicine. Springer-Verlag. Berlin, pp 123–134
Lachmann B (1992) Open up the lung and keep the lung open. Intensive Care Med 18: 319–321
Laggner AN, Lenz K, Grimm G, Sommer G, Goessinger H (1987) Haemofiltration zur Reduktion des Lungenwassers beim ARDS? Schweiz Med Wochenschr 117: 445–459
Langer M, Mascheroni D, Marcolin R, Gattioni L (1988) The prone position in ARDS patients. Chest 94: 103–107
Larocco A, Amundson DE, Wallace MR, Malone JL, Oldfield EC (1992) Corticosteroids for pneumocystis-carinii pneumonia with acute respiratory failure: experience with rescue therapy. Chest 102: 892–895
Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF (1988) Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 138: 62–68
Malik AB (1983) Pulmonary microembolism. Physiol Rev 63: 1114–1207
Marini JJ, Kelsen SG (1992) Re-targeting ventilatory objectives in adult respiratory distress syndrome. Am Rev Respir Dis 146: 2–3
Meduri GU, Belenchia JM, Estes RJ, Wunderink RG, El Torky M, Leeper KV Jr (1991) Fibroproliferative phase of ARDS: clinical findings and effects of corticosteroids. Chest 100: 943–952
Mélot C, Lejeune P, Leeman M, Moraine JJ, Naeije R (1989) Prostaglandin E1 in the adult respiratory distress syndrome: benefit for pulmonary hypertension and cost for pulmonary gas exchange. Am Rev Respir Dis 139: 106–116
Mitchell JP, Schuller D, Calandrino FS, Schuster DP (1992) Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis 145: 990–998
Mustard RA, Bohnen JMA, Rosati C, Schouten D (1991) Pneumonia complicating abdominal sepsis: an independent risk for mortality. Arch Surg 126: 170–175
National Heart Lung, and Blood Institute (1979) Extracorporeal support for respiratory insufficiency. In: Diseases, Division of Lung (ed) A Collaborative Study in Response to RFPNHLI-73-20
Nor-wood SH, Civetta JM (1985) Ventilatory support in patients with ARDS. Surg Clin North Am 65: 895–915
Parker JC, Hernandez LA, Longenecker GL, Peevy K, Johnson W (1990) Lung edema caused by high peak inspiratory pressures in dogs: role of increased microvascular filtration pressure and permeability. Am Rev Respir Dis 142: 321–328
Pham LH, Brun-Buisson C, Legrand P, Rauss A, Verra F, Brochard L, Lemaire F (1991) Diagnosis of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 143: 1058–1061
Pison U, Seeger W, Buchhorn R, Joka T, Brand M, Obertacke U, Neuhof H, SchmittNeuerburg KP (1989) Surfactant abnormalities in patients with respiratory failure following multiple trauma. Am Rev Respir Dis 140: 1033–1039
Prost JF, Desché P, Jardin F, Margairaz A (1991) Comparison of the effects of intravenous almitrine and positive end-expiratory pressure on pulmonary gas exchange in adult respiratory distress syndrome. Eur Respir J 4: 683–687
Pugin J, Auckenthaler R, Lew DP, Suter PM (1991) Oropharyngeal decontamination decreases incidence of ventilator associated pneumonia. JAMA 265: 2704–2710
Radermacher P, Santak B, Becker H, Falke KJ (1989) Prostaglandin E1 and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. Anesthesiology 70: 601–606
Radermacher P, Santak B, Wüst HJ, Tarnow J, Falke KJ (1990) Prostacyclin and right ventricular functions in patients with pulmonary hypertension associated with ARDS. Intensive Care Med 16: 227–232
Ranieri VM, Eissa NT, Corbeil C, Chassé M, Braidy J, Matar N, Milic-Emili J (1991) Effects of positive end-expiratory pressure on alveolar recruitment and gas exchange in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 144: 544–551
Reidy JJ, Ramsay G (1990) Clinical trials of selective decontamination of the digestive tract: a review. Crit Care Med 18: 1449–1456
Reines HD, Silverman H, Hurst J, Warren J, Rotello WL, Horton J, Pattishall E (1990) Effects of two concentrations of nebulized surfactant (exosurf) in sepsis-induced adult respiratory distress syndrome (ARDS). Crit Care Med 20: S61
Reinhart K, Hannemann L, Kuss B (1990) Optimal oxygen delivery in critically ill patients. Intensive Care Med 16: 149–155
Repine JE, Beehler CJ (1991) Neutrophils and adult respiratory distress syndrome: two interlocking perspectives in 1991. Am Rev Respir Dis 144: 251–252
Reyes A, Lopez-Messa JB, Alonso P (1987) Almitrine in acute respiratory failure: effects on pulmonary gas exchange and circulation. Chest 91: 388–393
Reyes A, Roca J, Rodriguez-Roisin R, Torres A, Ussetti P, Wagner PD (1988) Effect of almitrine on ventilation-perfusion distribution in adult respiratory distress syndrome. Am Rev Respir Dis 137: 1062–1067
Rinaldo JE, Rogers RM (1986) Adult respiratory distress syndrome. N Engl J Med 315: 578–579
Rinaldo JE, Christman JW (1990) Mechanisms and mediators of the adult respiratory distress syndrome. Clin Chest Med 11: 621–632
Rodriguez-Roldan JM, Altuna-Cuesta A, Lopez A, Carillo A, Garcia J, Leon J, Martinez-Pellus AJ (1990) Prevention of nosocomial lung infection in ventilated patients: use of an antimicrobial pharyngeal nonabsorbable paste. Crit Care Med 18: 1239–1242
Rossaint R, Lopez S, Falke KJ, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328: 399–405
Rossignon MD, Khayat D, Royer C, Rouby JJ, Jacquillat C, Viars P (1990) Functional and metabolic activity of polymorphonuclear leukocytes from patients with adult respiratory distress syndrome: results of a randomized double-blind placebo-controlled study on the activity of prostaglandin E1. Anesthesiology 72: 276–281
Russell JA, Ronco JJ, Dodek PM (1990) Physiologic effects and side effects of prostaglandin E1 in the adult respiratory distress syndrome. Chest 97: 684–692
Saldeen T (1979) The Microembolism Syndrome. Gotab Press, Uppsala
Schuller D, Mitchell JP, Calandrino FS, Schuster DP (1991) Fluid balance during pulmonary edema: is fluid gain a marker or a cause of poor outcome? Chest 100: 1068–1075
Seear MD, Hannam VL, Kaapa P, Usha Raj J, O'Brodovich HM (1990) Effect of pentoxyfyline on hemodynamics: alveolar fluid reabsorption and pulmonary edema in a model of acute lung injury. Am Rev Respir Dis 142: 1083–1087
Seeger W, Neuhof H, Hall J, Roka L (1988) Pulmonary vasoconstrictor response to soluble fibrin in isolated lungs: possible role of thromboxane generation. Circ Res 62: 651–659
Seeger W, Guenther A, Walmrath HD, Grimminger F, Lasch HG (1993) Alveolar surfactant and adult respiratory distress syndrome. Clin Invest 71: 177–190
Seidenfeld JJ, Pohl DF, Bell RC, Harris GD, Johanson WG Jr (1986) Incidence, site and outcome of infections in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 134: 12–16
Shoemaker WC (1990) Was a magic bullet aimed in the right direction? Chest 98: 405–410
Shoemaker WC, Appel PL (1986) Effects of prostaglandin E1 in adult respiratory distress syndrome. Surgery 99: 275–282
Silverman HJ, Slotman G, Bone RC, Maunder R, Hyers TM, Kerstein MD, Ursprung JJ (1990) Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Chest 98: 405–1110
Simmons RS, Berdine GG, Seidenfeld JJ, Prihoda TJ, Harris GD, Smith JD, James Gilbert T, Mota E, Johanson WG Jr (1987) Fluid balance and the adult respiratory distress syndrome. Am Rev Respir Dis 135: 924–929
Sloane PJ, Gee MH, Gottlieb JE, Fish JE, Burns JR, Machiedo G (1991) Markedly positive fluid balance in nonsurviving patients with ARDS (adult respiratory distress syndrome) (abstract). Am Rev Respir Dis 143: 683
Snider GL (1988) ARDS, neutrophils, and pentoxifylline. Am Rev Respir Dis 138: 1103–1105
Spragg RG, Gilliard N, Richman PS, Smith RM, Hite RD, Pappert D, Robertson B, Curstedt T, Strayer D (1994) Acute effect of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 105: 195–202
Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, Duncan RC, Tendler MD, Karpf M (1984) The effects of high-dose corticosteroids in patients with septic shock. N Engl J Med 311: 1137–1143
Stoutenbeek CP, Van Saene HKF (1992) Prevention of pneumonia by selective decontamination of the digestive tract (SDD). Intensive Care Med 18: S18-S23
Sturm JA (1991) Adult respiratory distress syndrome. Springer-Verlag, Berlin
Swami A, Keogh BF (1992) The injured lung: conventional and novel respiratory therapy. Thorax 47: 555–562
Sznajder JI, Wood LDH (1991) Beneficial effects of reducing pulmonary edema in patients with acute hypoxemic respiratory failure. Chest 100: 890–891
Torres A, Aznar R, Gatell JM, Jiménez P, González J, Ferrer A, Celis R, Rodriguez-Roisin R (1990) Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 142: 523–528
Tryba M (1987) Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care patients: sucralfate versus antacids. Am J Med 83 (suppl): 177–124
Tsuno K, Miura K, Takeya M, Kolobow T, Morioka T (1991) Histopathologic pulmonary changes from mechanical ventilation at high peak airway pressures. Am Rev Respir Dis 143: 1115–1120
Tuxen DV, Cade JF (1986) Effect of aprotinin in adult respiratory distress syndrome. Anaesth Intensive Care 14: 390–399
Van Saene HKF, Stoutenbeek CC, Stoller JK (1992) Selective decontamination of the digestive tract in the intensive care unit: current status and future prospects. Crit Care Med 20: 691–703
Veterans Administration Systemic Sepsis Cooperative Study Group (1987) Effect of highdose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317: 659–665
Villar J, Slutsky AS (1989) The incidence of the adult respiratory distress syndrome. Am Rev Respir Dis 140: 814–816
Vincent JL (1990) The relationship between oxygen demand, oxygen uptake, and oxygen supply. Intensive Care Med 16: 145–148
Vincent JL, Roman A, de Backer D, Kahn RJ (1990) Oxygen uptake/supply dependency: effects of short-term dobutamine infusion. Am Rev Respir Dis 142: 2–7
Von Segesser LK, Schaffner A, Stocker R, Lachat M, Speich R, Baumann PC, Turina M (1992) Extended (29 days) use of intravascular gas exchanger (letter). Lancet 339: 1536
Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W (1993) Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 342: 961–962
Webster NR, Cohen AT, Nunn JF (1988) Adult respiratory distress syndrome: how many cases in the UK? Anaesthesia 43: 923–926
Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, Gadek JE (1986) Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysiologic significance. Am Rev Respir Dis 133: 218–225
Wetterberg T, Steen S (1991) Total extracorporeal lung assist: a new clinical approach. Intensive Care Med 17: 73–77
Wheeler AP, Bernard GR (1988) Minimal positive end expiratory pressure (PEEP): a safe, effective, defensible practice. Clin Intensive Care 175–179
Wiedemann H, Baughman R, deBoisblanc B, Schuster D, Caldwell E, Weg J, Balk R, Jenkinson S, Wiegelt J, Tharratt R, Horton J, Pattishall E, Long W (1992) Multicenter trial in human sepsis-induced ARDS of an aerosolized synthetic surfactant (exosurf) (abstract). Am Rev Respir Dis 145: 184
Zabel P, Schönhärting MM, Wolter DT, Schade OF (1989) Oxpentifylline in endotoxaemia. Lancet 30: 1474–1477
Zapol WM (1991) A nordic ECMO saga or whither ECMO. Intensive Care Med 17: 69–70
Author information
Authors and Affiliations
Additional information
Offprint requests to: B. Temmesfeld-Wollbrück
Rights and permissions
About this article
Cite this article
Temmesfeld-Wollbrück, B., Walmrath, D., Grimminger, F. et al. Prevention and therapy of the adult respiratory distress syndrome. Lung 173, 139–164 (1995). https://doi.org/10.1007/BF00175656
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00175656